HOME >> BIOLOGY >> NEWS
OSA symptoms more common among African-American women than Caucasians

WESTCHESTER, Ill. In a study that examined the relationship between race, menopausal status and symptoms of obstructive sleep apnea (OSA), middle-aged African-American women were found to be more likely to experience OSA symptoms than their Caucasian counterparts, according to a research abstract that will be presented Monday at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

Elizabeth Beothy, of the University of Pennsylvania, who authored the study, administered a questionnaire to 269 subjects, with an average age of 48, and 49.4 percent of which were African-American. Further, 37.5 percent of women were pre-menopausal, 43 percent in the menopausal transition and 19.5 percent post-menopausal.

The mean apnea score among African-American women was nearly double that of Caucasian women. Menopausal status was not a significant predictor of OSA symptoms. Race remained a significant predictor of OSA symptoms after adjustment for current body mass index (BMI), BMI change over time and menopausal status.

"Although menopausal status did not predict OSA symptoms, OSA symptoms on our cohort of menopausal women increased with higher BMI and larger BMI increases over time," said Beothy, who added that studies to document whether OSA is more common among African-American women than Caucasian women should be performed to further investigate these findings.

OSA affects an estimated 15 million to 20 million Americans, as well as millions more who remain undiagnosed and untreated.

Scientific evidence shows that CPAP is the best treatment for sleep apnea. CPAP provides a steady stream of pressurized air to patients through a mask that they wear during sleep. This airflow keeps the airway open, preventing the pauses in breathing that characterize OSA and restoring normal oxygen levels.


'"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
11-Jun-2007


Page: 1

Related biology news :

1. Manganese levels increase in scrapie-infected sheep before clinical symptoms develop
2. MIT researchers reverse symptoms in mice of leading inherited cause of mental retardation
3. Latest data shows MabThera provides significant, sustained relief from symptoms of RA
4. Gene malfunctions cause schizophrenia, depression symptoms in mice
5. Switching genes to overdrive improves muscular dystrophy symptoms in mice
6. Reversal of symptoms in an autism spectrum disorder
7. Malaria drug may treat metabolic syndromes many symptoms
8. Brain protein improves stroke symptoms in rats, even when injected after 3 days
9. Rush and UCSF found gene therapy appeared to reduce symptoms of Parkinsons by 40 percent
10. Epilepsy drug eases symptoms of inherited disorder that weakens muscles
11. Researchers reverse Parkinsons symptoms in animal models

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. ... "Eating Well Made Simple," and 23andMe , the ... guide better food choices.  Zipongo can now provide customers ... food preferences, health goals and biometrics, but also genetic ... food choices. Zipongo,s personalized food decision support ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... PETACH TIKVAH, Israel , ... Inc. (NASDAQ: BCLI), a leading developer of ... announced financial results for the year ended ... a highly successful and pivotal year for Brainstorm, with ... progress made on clinical, regulatory and operational fronts," ...
(Date:3/29/2017)... LINCOLN, Mass. , March 29, 2017 ... industry-leader in applying mechanistic modeling to drug ... of their collaboration with Zymeworks Inc. for ... drug conjugate therapeutics intended for the treatment ... has supported Zymeworks previously for GLP toxicology ...
(Date:3/29/2017)... ... March 29, 2017 , ... ACEA ... assays, disperses a quarterly travel award to noteworthy scientists who will be presenting ... that its new round of awards are being given to two postdoctoral fellows ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Agricultural Chelates Market is poised to ... to reach approximately $825.4 million by 2025. This ... given segments on global as well as regional levels presented in ...
Breaking Biology Technology:
Cached News: